Lysophosphatidic acid is a potential mediator of cholestatic pruritus.

Author: BeuersUlrich, GeenesVictoria L, KondrackieneJurate, KremerAndreas E, KuiperEdith M M, KulikWim, MartensJob J W W, MoolenaarWouter H, Oude ElferinkRonald P J, PrietoJesus, RustChristian, RuëffFranziska, WilliamsonCatherine, van BuurenHenk R, van ErpecumKarel J

Paper Details 
Original Abstract of the Article :
BACKGROUND & AIMS: Pruritus is a common and disabling symptom in cholestatic disorders. However, its causes remain unknown. We hypothesized that potential pruritogens accumulate in the circulation of cholestatic patients and activate sensory neurons. METHODS: Cytosolic free calcium ([Ca(2+)](i)) wa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1053/j.gastro.2010.05.009

データ提供:米国国立医学図書館(NLM)

Lysophosphatidic Acid: A Potential Key to Understanding Cholestatic Pruritus

Cholestatic disorders, characterized by impaired bile flow, can cause intense and debilitating itching, known as pruritus. This study investigated the potential role of lysophosphatidic acid (LPA) in mediating cholestatic pruritus. The researchers found that LPA levels were elevated in the serum of patients with cholestatic disorders experiencing pruritus, suggesting a potential link between LPA and this symptom.

Unraveling the Mystery: LPA and Cholestatic Pruritus

The study found that serum samples from patients with cholestatic disorders and pruritus induced transient increases in neuronal cytosolic free calcium ([Ca(2+)](i)), a marker of neuronal activation. They further identified LPA as a major [Ca(2+)](i)-inducing factor in these serum samples and discovered that LPA concentrations were elevated in cholestatic patients with pruritus. Additionally, the study showed that LPA injection into mice induced scratching behavior, further supporting its role in pruritus.

Seeking Relief: Future Therapeutic Targets

This study provides compelling evidence for the potential role of LPA in mediating cholestatic pruritus. The findings suggest that LPA and its precursor enzyme, autotaxin, could be potential targets for future therapeutic interventions aimed at alleviating the debilitating itching associated with cholestatic disorders. Further research is needed to explore the clinical implications of these findings and to develop effective therapies targeting LPA and autotaxin.

Dr.Camel's Conclusion

Like a camel seeking water in the desert, researchers are diligently searching for solutions to alleviate the intense itching associated with cholestatic disorders. This study sheds light on the potential role of LPA in mediating pruritus, opening up exciting possibilities for developing new and effective treatments for this debilitating condition. The future holds promise for finding relief from this persistent and often overlooked symptom, improving the quality of life for patients suffering from cholestatic disorders.

Date :
  1. Date Completed 2010-09-20
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

20546739

DOI: Digital Object Identifier

10.1053/j.gastro.2010.05.009

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.